These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4433757)

  • 21. [Morphological changes of thrombocytes following blood withdrawal and during thrombus formation].
    Wiedemann R; Breddin K
    Med Welt; 1978 Jul; 29(27-28):1146-8. PubMed ID: 672585
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thrombocytes].
    Breddin K
    Dtsch Med J; 1971 Dec; 22(24):766-70. PubMed ID: 5157755
    [No Abstract]   [Full Text] [Related]  

  • 23. [Structural and functional changes in thrombocytes in experimental atherosclerosis].
    Gorbatenkova EA; Azizova OA; Dubrovin MIu; Sergienko VI; Khalilov EM
    Biull Eksp Biol Med; 1984 Feb; 97(2):149-52. PubMed ID: 6320926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insufficiency of the aggregation function of thrombocytes in the genesis of juvenile unterine hemorrhage].
    Kheĭfets SN; Perfil'eva GN; Fadeeva NI; Shteĭngauer VV
    Vopr Okhr Materin Det; 1975 May; 20(5):65-9. PubMed ID: 1146261
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood platelet functional state and exposure to an aggregation inducer].
    Markosian RA; Popov EG; Radin AIu; Gabbasov ZA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(2):47-51. PubMed ID: 7317159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. II. Relationships among platelet adhesion, thrombus dimensions, and fibrin formation.
    Baumgartner HR; Turitto V; Weiss HJ
    J Lab Clin Med; 1980 Feb; 95(2):208-21. PubMed ID: 7354233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cyclonamine on blood platelets. II. Changes in the surface charge and inhibition of the release reaction.
    Sack ES; Cerutti N
    Medicina (B Aires); 1973; 3(6):685-94. PubMed ID: 4805048
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serotonin liberation in human thrombocytes through a platelet-aggregating plasma factor].
    Bamberg E; Breddin K
    Verh Dtsch Ges Inn Med; 1974; 80():1443-5. PubMed ID: 4454450
    [No Abstract]   [Full Text] [Related]  

  • 29. [Disorders of the functional properties of thrombocytes causing thromboembolism in acute suppurative destructive diseases of the lungs and pleura].
    Tulupov AN; Bel'skikh AN
    Vestn Khir Im I I Grek; 1986 Aug; 137(8):9-13. PubMed ID: 3765295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of the thrombocytes in the induction of intravascular coagulation].
    Evensen SA; Jeremic M; Hjort PF
    Bibl Haematol; 1969; 32():292-7. PubMed ID: 5822809
    [No Abstract]   [Full Text] [Related]  

  • 31. Simulation of platelet adhesion and aggregation regulated by fibrinogen and von Willebrand factor.
    Mori D; Yano K; Tsubota K; Ishikawa T; Wada S; Yamaguchi T
    Thromb Haemost; 2008 Jan; 99(1):108-15. PubMed ID: 18217141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic study of fibrinogen and its split products in venous thrombosis.
    Sova J
    Acta Univ Carol Med Monogr; 1972; 52():173-9. PubMed ID: 4593289
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
    Haas S; Ketterl R; Blümel G
    Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advances in the physiopathology of the platelet membrane (author's transl)].
    Ruan C; Kieffer N; Tobelem G
    Pathol Biol (Paris); 1982 Feb; 30(2):69-72. PubMed ID: 6806766
    [No Abstract]   [Full Text] [Related]  

  • 35. [Description of an apparatus for the study in vitro of blood platelet aggregation].
    Bologna E
    Boll Soc Ital Biol Sper; 1969 Aug; 45(15):1025-6. PubMed ID: 5374896
    [No Abstract]   [Full Text] [Related]  

  • 36. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thrombocytes during the neonatal period].
    Maak B; Frenzel J
    Kinderarztl Prax; 1981 Jun; 49(6):281-92. PubMed ID: 7021958
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hereditary thrombocytopathies - models for the study of the molecular and biochemical basis of thrombocyte function].
    Elezović I; Rolović Z
    Bilt Hematol Transfuz; 1980; 8(1):3-18. PubMed ID: 7039613
    [No Abstract]   [Full Text] [Related]  

  • 39. First component of complement and thrombosis.
    Wautier JL; Ollier-Hartmann MP; Kadeva H; Cohen F; Hartmann L; Caen JP
    Thromb Haemost; 1981 Jun; 45(3):247-51. PubMed ID: 7281103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.